Decibio Champions Data Solutions to Give Edge to Life Science Companies - Los Angeles Business Journal

2 years ago 63

Strategic consultation institution DeciBio is leaning connected the powerfulness of information to grip the expanding introduction fees needed by companies to vie successful a precision medicine abstraction dominated by deep-pocketed organizations.

With 4 proprietary penetration databases and 2 marketplace platforms included successful its offerings, the Century City-based institution sees information arsenic the mode to pull and clasp startup clients that scope from mid- to large-scale diagnostic and beingness subject tools companies to pharmaceutical and integer wellness organizations.

David Cavanaugh (left) and Stephane Budel with their bobblehead likeness successful  the DeciBio headquarters.BeciBio’s David Cavanaugh (left) and Stephane Budel.

“The thought implicit the past 9 years has been to effort to find ways to interact with arsenic galore of the cardinal stakeholders successful precision medicine (as possible),” said David Cavanaugh, DeciBio’s vice president. “We privation to beryllium astatine the halfway of this multi-dimensional hub of precision medicine.”

The company’s penetration databases see MarketBook and DxBooks.
MarketBook is simply a predictive information exemplary that tracks, segments and forecasts revenues of much than 100 beingness subject probe tools companies, including ThermoFisher and Bio-Rad Laboratories.

DeciBio refers to the probe tools marketplace arsenic 1 that produces instruments, reagents and different technologies that are acquired arsenic portion of aesculapian research, arsenic opposed to tools being utilized for patients.

“The thought (with MarketBook) is to person this precise granular presumption of this marketplace and bash it successful a holistic way, truthful clients recognize each the moving parts,” Cavanaugh said.

Meanwhile, the DxBooks database provides accusation connected home labs’ investigating behaviors successful the areas of oncology biomarkers, infectious illness diagnostics and Covid-19 testing.

DeciBio has built DxBooks via surveys of infirmary labs to spot what tests are being conducted and which instruments are being utilized to behaviour those tests. For instance, oncology biomarker investigating accusation is derived from astir 300 infirmary and notation labs annually passim the United States.

The information produced allows clients utilizing DxBooks to amended recognize the evolving marketplace stock of aesculapian instruments.

Funding

These database services are offered to clients done subscription models, the outgo of which DeciBio did not disclose. Other database services see I/O BioMap and TheraTrack.
“We cognize that our clients get frustrated erstwhile they enactment with different work providers successful which they extremity up having to amended (the work providers) connected the market. For us, we’ve ever had this heavy knowing of the size of the markets, maturation rates and marketplace shares,” Cavanaugh said. “All this accusation makes it overmuch easier to really absorption connected wherefore clients travel to america typically, which is to lick a concern problem.”

In the cases of smaller companies seeking to usage DeciBio’s consulting oregon information services, DeciBio finds alternate forms of payment, according to Stephane Budel, the company’s founding partner.

“We’re consenting to stock the hazard that comes with launching a merchandise and fundamentally instrumentality equity oregon indebtedness arsenic a signifier of outgo for immoderate of these tiny companies, truthful that enables america to enactment passim the full acceptable of companies that represent that space,” Budel said.
He added that DeciBio finds ways to enactment with smaller companies either done the company’s task superior limb oregon the information arm, wherever it tin connection products astatine a much affordable terms point. DeciBio launched its task superior and instauration firm, DeciBio Ventures, past December.

DeciBio Ventures focuses its investments connected startups successful the tools and therapeutics markets. In a property release, the task superior steadfast said portfolio companies would beryllium capable to leverage DeciBio Analytics’ products, solutions, and services to summation market-level insights.

In July, DeciBio Ventures participated successful a seed-funding circular for genomic medicine exertion developer Replay that totaled $55 million. KKR & Co. and OMX Ventures led the backing round.

Ahmed Enany, main enforcement of the Southern California Biomedical Council successful Los Angeles, said that though an abundance of progressive life-science consulting firms, the absorbing happening astir DeciBio is its task superior arm.

“It helps them pull clients who whitethorn beryllium funny successful tapping their task money for early-stage funding,” Enany said. “This is an emerging inclination among consultancy firms that extremity up creating concern arms to instrumentality vantage of hyper-growth opportunities.”

Startup strategy

Cavanaugh said that astatine its core, DeciBio has been focused connected information and consulting services and that the concern limb was created due to the fact that of the company’s involvement successful getting further progressive with startups.

“It’s absorbing due to the fact that we are a strategy consulting steadfast ourselves, truthful it’s rather important to fig retired what you privation to absorption on,” Budel said. “What is it that you privation to bash and not do? Finding the equilibrium betwixt that (is important).”

According to Cavanaugh, DeciBio is expanding its task superior beingness and is besides successful the process of raising funds with a spouse to put successful startup companies.
Cavanaugh said DeciBio, though a tiny firm, has tried to emulate ample firms that person dedicated teams of scientists successful spot for the improvement and attraction of information solutions.

He added that the information solutions and platforms offered by DeciBio are important investments for the company.

“It means taking wealth that we marque on, say, the consulting side, and reinvesting that into information products that tin instrumentality a twelvemonth oregon 2 earlier you really spot them carnivore effect and revenue,” Cavanaugh said. “An illustration is the adept web we’re building, and we’ve been moving connected that for a fig of years.”

The web referred to by Cavanaugh is called Dexter, a level that allows clients to link with the company’s web of beingness subject advisors via interviews oregon surveys that nutrient insights designed to measure the market’s appetite for a work oregon merchandise oregon assistance with the motorboat of a project.

Dexter follows a pay-as-you-go pricing exemplary and has nary onboarding fees oregon yearly contracts.
“We’re bringing that to radical astatine a precise tiny scale,” Cavanaugh said. “Someone tin travel and say, ‘I privation to speech to 10 of the world’s starring oncologists progressive successful aboriginal detection successful cancer,’ and we tin assistance them bash that.”

Cavanaugh said the web gives clients the enactment betwixt six-figure consultation projects oregon a importantly cheaper level similar Dexter to summation insights.
The institution besides produces and sells marketplace reports that tin beryllium purchased with idiosyncratic user, tract oregon planetary licenses. An idiosyncratic individual licence for the company’s oncology biomarker marketplace appraisal costs a one-time interest of $5,300.

Read Entire Article